Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Signal Twitter WhatsApp

Ryann Grochowski Jones

Data Reporter

Photo of Ryann Grochowski Jones

Ryann Grochowski Jones is a data reporter at ProPublica. Previously, she was a data reporter for Investigative Newsource/KPBS in San Diego, Calif. She received her masterâs degree from the University of Missouri School of Journalism, where she was a data librarian for Investigative Reporters and Editors/National Institute for Computer-Assisted Reporting. Ryann started her career as a municipal beat reporter for her hometown newspaper in Wilkes-Barre, Pa.

One Nation, Under Sedation: Medicare Paid for Nearly 40 Million Tranquilizer Prescriptions in 2013

Congress wouldn’t allow Medicare to pay for benzodiazepines such as Xanax and Ativan until 2013. Now, the medications are among the most prescribed in its drug program.

Money as a Weapons System

How U.S. commanders spent $2 billion of petty cash in Afghanistan

One Year, 2,000+ Downloads: Here’s How Our Data Store Is Doing

A year after we launched it, here’s what our Data Store looks like.

Uber Claims Credit for Drop in Drunk Driving Accidents. But Where's the Evidence?

The ridesharing service published a report last week with Mothers Against Drunk Driving connecting the rise of Uber to a drop in drunk driving accidents. Except the connection isn't so clear.

Why Pharma Payments to Doctors Were So Hard to Parse

Flaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis.

Vying for Market Share, Companies Heavily Promote 'Me Too' Drugs

Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.

Open Payments Explorer: How Much Industry Money Goes to Doctors and Teaching Hospitals

Beginning in 2014, the federal government mandated that pharmaceutical and medical device manufacturers publicly report payments made to doctors and teaching hospitals. The first report covered the last five months of 2013. Use this tool to search for a company, drug or device — and compare it to another.

Methodology for Calculating Company Payments to Doctors

Even with new federal data, it's not easy to track drug, device company spending on their products

Answering the Critics of our Deadly Force Story

We respond to arguments levied against our analysis of justified homicides by police officers.

As Controlled Substance Use Rises in Medicare, Prolific Prescribers Face More Scrutiny

Despite warnings about abuse, Medicare covered more prescriptions for potent controlled substances in 2012 than it did in 2011. The program's top prescribers often have faced disciplinary action or criminal charges related to their medical practices.

Big Changes in Fine Print of Some 2015 Obamacare Plans

A ProPublica analysis found that many health insurance plans offered in the federal Affordable Care Act marketplace are changing their benefits heading into 2015. Consumers have until Dec. 15 to switch plans before they are automatically re-enrolled.

Deadly Force, in Black and White

A ProPublica analysis of killings by police shows outsize risk for young black males.

What We've Learned From Four Years of Diving Into Dollars for Docs

Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.

How New York and Illinois Curb a Key Labor Violation While Other States Fall Short

The states have passed hard-nosed laws and taken an aggressive tack toward employers who misclassify independent contractors.

The Road to Health is Paved With Good Data

The nonprofit Health Data Consortium held its fifth-annual Health Datapalooza last week in Washington, D.C. Here are some highlights.

How We Analyzed Medicare Part B Data

Using recently released Medicare data, we examined how doctors and other health professionals billed for office visits, one of the most common services patients receive. We found some doctors who billed for the most costly, most complex visits almost exclusively and charged top rates far more than their peers.

Treatment Tracker

Medicare recently released, for the first time, details on 2012 payments to individual doctors and other health professionals serving the 46 million seniors and disabled in its Part B program. Part B covers services as varied as office visits, ambulance mileage, lab tests, and the doctor’s fee for open-heart surgery. Use this tool to find and compare providers.

Top Billing: Meet the Docs who Charge Medicare Top Dollar for Office Visits

Medicare paid for more than 200 million office visits for established patients in 2012. Overall, health professionals classified only 4 percent as complex enough to command the most expensive rates. But 1,800 providers billed at the top level at least 90 percent of the time, a ProPublica analysis found. Experts question whether the charges are legitimate.

Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their Research

Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analyzed. That raises questions about doctors’ impartiality.

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies will be required to report payments to doctors.

Follow ProPublica

Our Latest Stories

Current site Current page